STAAR Surgical Company Forecast, price target & analysts
STAAR Surgical Company Target price 2025 - Analyst rating & recommendation
STAAR Surgical Company Classifications & Recommendation:
STAAR Surgical Company Price Target
| Target Price | $28.56 |
| Price | $23.63 |
| Potential |
20.86%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target STAAR Surgical Company 2026 .
The average STAAR Surgical Company target price is $28.56.
This is
20.86%
register free of charge
$29.40
24.42%
register free of charge
$16.16
31.61%
register free of charge
|
|
| A rating was issued by 14 analysts: 0 Analysts recommend STAAR Surgical Company to buy, 11 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the STAAR Surgical Company stock has an average upside potential 2026 of
20.86%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 313.90 | 262.57 |
| 2.64% | 16.35% | |
| EBITDA Margin | -2.13% | 1.84% |
| 120.69% | 186.33% | |
| Net Margin | -6.44% | -23.04% |
| 197.23% | 257.86% |
11 Analysts have issued a sales forecast STAAR Surgical Company 2025 . The average STAAR Surgical Company sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an STAAR Surgical Company EBITDA forecast 2025. The average STAAR Surgical Company EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 STAAR Surgical Company Analysts have issued a net profit forecast 2025. The average STAAR Surgical Company net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.41 | -1.23 |
| 195.35% | 200.00% | |
| P/E | negative | |
| EV/Sales | 3.74 |
11 Analysts have issued a STAAR Surgical Company forecast for earnings per share. The average STAAR Surgical Company EPS is
This results in the following potential growth metrics and future valuations:
STAAR Surgical Company...
Current STAAR Surgical Company Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Sidoti & Co. |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 06 2025 |
|
Locked
Sidoti & Co.:
Locked
➜
Locked
|
Aug 05 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 27 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
